Imaging features and evaluation of liver lesions after non-surgical therapy

被引:3
作者
Delumeau, S. [1 ]
Lebigot, J. [1 ]
Ridereau-Zins, C. [1 ]
Bouvier, A. [1 ]
Boursier, J. [2 ]
Aube, C. [1 ]
机构
[1] CHU Angers, Serv Radiol A, F-49100 Angers, France
[2] CHU Angers, Serv Hepatogastroenterol, F-49100 Angers, France
来源
JOURNAL DE RADIOLOGIE | 2011年 / 92卷 / 7-8期
关键词
Radiofrequency; Chemoembolization; Targeted therapy; Chemotherapy; Evaluation criteria; Response; RESPONSE EVALUATION CRITERIA; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; TUMOR RESPONSE; NEOADJUVANT CHEMOTHERAPY; COLORECTAL-CANCER; METASTASES; MANAGEMENT; MICROSPHERES; BEVACIZUMAB;
D O I
10.1016/j.jradio.2011.04.014
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The main non-surgical treatments for liver lesions include chemotherapy, targeted treatments, chemoembolization and radiofrequency ablation. The post-treatment imaging features are variable and depend on the initial appearance of the lesion, the type of treatment and the imaging modality. Evaluation of tumour response to treatment is important. RECIST criteria based on unidimensional lesion measurements may not always be appropriate. Other evaluation criteria (Choi for GIST, EASL for HCC or Chun criteria.) may be more relevant. (C) 2011 Published by Elsevier Masson SAS.
引用
收藏
页码:632 / 658
页数:27
相关论文
共 39 条
[1]   Phase II study of sorafenib in patients with advanced hepatocellular carcinoma [J].
Abou-Alfa, Ghassan K. ;
Schwartz, Lawrence ;
Ricci, Sergio ;
Amadori, Dino ;
Santoro, Armando ;
Figer, Arie ;
De Greve, Jacques ;
Douillard, Jean-Yves ;
Lathia, Chetan ;
Schwartz, Brian ;
Taylor, Ian ;
Moscovici, Marius ;
Saltz, Leonard B. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (26) :4293-4300
[2]   Impact of Chemotherapy on the Accuracy of Computed Tomography Scan for the Evaluation of Colorectal Liver Metastases [J].
Angliviel, Benjamin ;
Benoist, Stephane ;
Penna, Christophe ;
El Hajjam, Mostafa ;
Chagnon, Sophie ;
Julie, Catherine ;
Beauchet, Alain ;
Rougier, Philippe ;
Nordlinger, Bernard .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (05) :1247-1253
[3]   Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases [J].
Benoist, S ;
Pautrat, K ;
Mitry, E ;
Rougier, P ;
Penna, C ;
Nordlinger, B .
BRITISH JOURNAL OF SURGERY, 2005, 92 (09) :1155-1160
[4]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[5]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[6]   Response evaluation of gastrointestinal stromal tumors [J].
Choi, Haesun .
ONCOLOGIST, 2008, 13 :4-7
[7]   Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: Feasibility and safety [J].
Chopra, S ;
Dodd, GD ;
Chanin, MP ;
Chintapalli, KN .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 180 (03) :697-701
[8]   Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases [J].
Chun, Yun Shin ;
Vauthey, Jean-Nicolas ;
Boonsirikamchai, Piyaporn ;
Maru, Dipen M. ;
Kopetz, Scott ;
Palavecino, Martin ;
Curley, Steven A. ;
Abdalla, Eddie K. ;
Kaur, Harmeet ;
Charnsangavej, Chusilp ;
Loyer, Evelyne M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (21) :2338-2344
[9]   Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization [J].
Chung, Johnathan C. ;
Naik, Neel K. ;
Lewandowski, Robert ;
Deng, Jie ;
Mulcahy, Mary F. ;
Kulik, Laura M. ;
Sato, Kent T. ;
Ryu, Robert K. ;
Salem, Riad ;
Larson, Andrew C. ;
Omary, Reed A. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (25) :3161-3167
[10]  
De Matteo RP, 2008, GASTR CANC S